Background: First-degree biological relatives of individuals with breast cancer have a higher risk of breast cancer. Objective: The purpose of this study was to create a protocol for evaluating the effect of the Breast Cancer Risk Reduction Program (BrCaRRP) on the participation of women at risk in screening and on their health beliefs and risk reduction behaviors. Methods: The research was planned as a single-site, single-blind randomized controlled experimental study with a parallel group. Participants will be assigned to intervention and control groups using the Stratified Permuted Block Randomization method. The BrCaRRP will be applied to the intervention group within the theoretical framework of the Health Belief Model and the Health Promotion Model. The BrCaRRP is a 12-week program that encompasses 6 meetings, the first being face-to-face and the others via phone. Multidisciplinary experts calculated the content validity index of BrCaRRP as being 0.954 (high); its weighted kappa statistic is 0.70 (high). Results: The difference in the likelihood of participation in breast cancer screening between the BrCaRRP and control groups will be evaluated after the interventions. Findings will be presented in terms of our hypotheses. Conclusions: The BrCaRRP is a nurse-led program based on the Health Belief Model and the Health Promotion Model. The BrCaRRP has high content validity and interrater reliability. Implications for Practice: This protocol can be tested as an intervention in a randomized controlled study.
Breast cancer is the most common type of cancer among women (Sung et al., 2021), creating a major health issue for women. In 2020, 2.3 million new breast cancer cases were reported, and 685,000 related deaths occurred (Sung et al., 2021). By 2040, annual new breast cancer cases and related deaths each year are expected to exceed three million and one million, respectively (Arnold et al., 2022). Breast cancer screening is effective in preventing deaths and mitigating the serious consequences of advanced cancer.
Background: Women with a family history of breast cancer at an early age (≤50 years) have an increased risk of breast cancer themselves. Objective: To evaluate the effectiveness of a Breast Cancer Risk Reduction Program (BrCaRRP) on increasing risk reduction behaviors, developing health beliefs, and screening participation in high-risk women with a family history of breast cancer. Methods: This is a single-center, single-blind, parallel-group, randomized controlled trial. First-degree biological relatives of breast cancer patients (aged ≤50 years) were divided into intervention (n = 38) and control (n = 39) groups. The intervention (BrCaRRP) group received multiple interventions including education, counseling, case management, and surveillance via face-to-face and telephone interviews throughout a 12-week period, within the framework of the Health Belief Model and Health Promotion Model. The control group was given an information note, and the routine practice of the clinic was performed. Results were measured at baseline and at week 12 when the interventions were finished. Results: The probability of participation in breast cancer screenings in the BrCaRRP group was 5.11 times higher. Health motivation was found to have increased in the intervention group. There was no difference in susceptibility and nutritional behavior between the groups. Health responsibility and physical activity increased in the intervention group. The frequency of consulting genetic counseling increased in the BrCaRRP group. Conclusions: Breast Cancer Risk Reduction Program increased participation in screening in women and positively affected their health beliefs and behaviors. Implications for Practice: Breast Cancer Risk Reduction Program could alter screening and health-promoting behaviors. However, other interventions are still needed to reduce the high level of fear.
The Consultation and Relational Empathy (CARE) measure was developed to create a means of evaluating a physician’s consultation process based on an extensive and meaningful definition of empathy, independent of a patient’s socioeconomic background. The aim of this study was to adapt the valid and reliable CARE measure into Turkish and to confirm the measure’s validity and reliability in the Turkish language. The measure reached its final version after the processes of translation, back-translation, and a pilot study. The final version of the measure was administered to 300 individuals between the ages of 18 and 83 who were patients at Akdeniz University Hospital. The internal consistency, homogeneity, and construct of the measure were assessed. The internal consistency and homogeneity of the measure were found to be very high (Cronbach’s alpha = 0.973; the corrected item–total correlation coefficient for all items > 0.816). The measure was found to have a single-factor structure with a high level of construct validity. It was additionally found that the CARE score was not affected by the patients’ demographic characteristics. The Turkish version of the CARE measure can be used as a valid and reliable measuring tool. The CARE measure is a tool with which patients can assess the level of empathy shown by a healthcare provider.
30 December 2022 in Clinical and Experimental Health Sciences
Objective: The aim of this study was to evaluate whether or not there were changes in the behaviors of relatives of cancer patients such as learning the warning signs of cancer, engaging in cancer prevention strategies, and participating in screenings after education sessions in the clinic. Methods: This one-group pretest-posttest study was conducted with 238 relatives in a medical oncology clinic in Antalya, Turkey. Individual education sessions were conducted as an intervention, banners were hung about cancer, and general health information on checkups in the form of leaflets were distributed to each relative regarding cancer screenings. Reminder messages were sent to individuals to participate in screenings one and two months after the first interview. The posttest data were collected by phone in the third month. Four questionnaires were prepared based on the literature and national cancer screening standards. The face validity of the tools was evaluated by three experts and 15 relatives who not included as participants. Results: The rate of having a mammography increased from 19.8% to 33.9%, rates of having the fecal occult blood test increased from 16.9% to 23.8%, and rates of having the HPV test increased from 43.5% to 49.6%. The rate of having blood pressure checks within the last 12 months increased from 75.8% to 83.1%, rates of blood cholesterol measurement increased from 68.5% to 79%, and rates of blood glucose measurement increased from 70.2% to 79%. Conclusion: Education provided to the relatives increased participation in screenings.